Photocure ASA

OB:PHO Stock Report

Market Cap: NOK 1.7b

Photocure Past Earnings Performance

Past criteria checks 3/6

Photocure's earnings have been declining at an average annual rate of -18.9%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 15.9% per year. Photocure's return on equity is 2.8%, and it has net margins of 2.7%.

Key information

-18.9%

Earnings growth rate

-19.3%

EPS growth rate

Pharmaceuticals Industry Growth12.4%
Revenue growth rate15.9%
Return on equity2.8%
Net Margin2.7%
Next Earnings Update19 Feb 2025

Recent past performance updates

We Think Photocure's (OB:PHO) Robust Earnings Are Conservative

Aug 14
We Think Photocure's (OB:PHO) Robust Earnings Are Conservative

Recent updates

Photocure ASA's (OB:PHO) Shares Leap 29% Yet They're Still Not Telling The Full Story

Dec 21
Photocure ASA's (OB:PHO) Shares Leap 29% Yet They're Still Not Telling The Full Story

We Think Photocure's (OB:PHO) Robust Earnings Are Conservative

Aug 14
We Think Photocure's (OB:PHO) Robust Earnings Are Conservative

Photocure ASA's (OB:PHO) P/S Still Appears To Be Reasonable

Jun 01
Photocure ASA's (OB:PHO) P/S Still Appears To Be Reasonable

Photocure ASA's (OB:PHO) 26% Jump Shows Its Popularity With Investors

Dec 18
Photocure ASA's (OB:PHO) 26% Jump Shows Its Popularity With Investors

Potential Upside For Photocure ASA (OB:PHO) Not Without Risk

Sep 01
Potential Upside For Photocure ASA (OB:PHO) Not Without Risk

Time To Worry? Analysts Just Downgraded Their Photocure ASA (OB:PHO) Outlook

Mar 01
Time To Worry? Analysts Just Downgraded Their Photocure ASA (OB:PHO) Outlook

Analyst Estimates: Here's What Brokers Think Of Photocure ASA (OB:PHO) After Its Second-Quarter Report

Aug 14
Analyst Estimates: Here's What Brokers Think Of Photocure ASA (OB:PHO) After Its Second-Quarter Report

We Think Photocure (OB:PHO) Can Stay On Top Of Its Debt

Aug 12
We Think Photocure (OB:PHO) Can Stay On Top Of Its Debt

Do Institutions Own Photocure ASA (OB:PHO) Shares?

Feb 11
Do Institutions Own Photocure ASA (OB:PHO) Shares?

Revenue & Expenses Breakdown

How Photocure makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OB:PHO Revenue, expenses and earnings (NOK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24526143614
30 Jun 24514133553
31 Mar 2451253502
31 Dec 2350113482
30 Sep 23462-343462
30 Jun 23462-393422
31 Mar 23418-623293
31 Dec 22393-723193
30 Sep 22383-793074
30 Jun 22364-762994
31 Mar 22354-682895
31 Dec 21361-312754
30 Sep 2136472617
30 Jun 21326923310
31 Mar 212901021411
31 Dec 20256-2220114
30 Sep 202741017814
30 Jun 202851517413
31 Mar 202841916513
31 Dec 192823216014
30 Sep 19216-2315315
30 Jun 19199-2714716
31 Mar 19192-3914018
31 Dec 18182-3713219
30 Sep 18171-3812323
30 Jun 18162-4317042
31 Mar 18156-3111428
31 Dec 17151-3510833
30 Sep 17150-410332
30 Jun 1714964513
31 Mar 17145299227
31 Dec 16144359023
30 Sep 1614089125
30 Jun 1614139126
31 Mar 16140-268730
31 Dec 15135-368431
30 Sep 15126-585331
30 Jun 15147-295731
31 Mar 15138-235931
31 Dec 14129-256433
30 Sep 14129-26533
30 Jun 1492-396534
31 Mar 1489-507134

Quality Earnings: PHO has high quality earnings.

Growing Profit Margin: PHO became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: PHO has become profitable over the past 5 years, growing earnings by -18.9% per year.

Accelerating Growth: PHO has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: PHO has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (9.5%).

Return on Equity

High ROE: PHO's Return on Equity (2.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/01 15:29
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Photocure ASA is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hans BohnBeringer Finance AB
null nullBrookline Capital Markets
Patrik LingDNB Markets